Gang-See Lee
Direktor/Vorstandsmitglied bei Nano-Ditech Corp.
Profil
Gang-See Lee currently works at Nano-Ditech Corp., as Director and Exollence Co., Ltd., as Outside Director.
Mr. Lee also formerly worked at i-SENS, Inc., as Director in 2014.
Mr. Lee received his graduate degree from Seoul National University.
Aktive Positionen von Gang-See Lee
| Unternehmen | Position | Beginn |
|---|---|---|
Nano-Ditech Corp.
 Nano-Ditech Corp. Medical SpecialtiesHealth Technology Nano-Ditech Corp. develops immuno-diagnostic products. It serves the point-of-care marketplace including medical professionals, physicians, clinical laboratories and hospitals. The firm focuses on rapid POCT immunoassays for the detection of drugs of abuse and cardiac markers in the emergency department. The company was founded in 2002 and is headquartered in Cranbury, NJ. | Direktor/Vorstandsmitglied | - |
Exollence Co., Ltd.
 Exollence Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Exollence Co., Ltd. operates as a South Korean drug delivery platform technology company. The company is based in Seoul, South Korea. The company was founded in 2019. The CEO is Ki-Hwan Kwon. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gang-See Lee
| Unternehmen | Position | Ende |
|---|---|---|
| I-SENS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Gang-See Lee
| Seoul National University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| I-SENS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Nano-Ditech Corp.
Nano-Ditech Corp. Medical SpecialtiesHealth Technology Nano-Ditech Corp. develops immuno-diagnostic products. It serves the point-of-care marketplace including medical professionals, physicians, clinical laboratories and hospitals. The firm focuses on rapid POCT immunoassays for the detection of drugs of abuse and cardiac markers in the emergency department. The company was founded in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Exollence Co., Ltd.
Exollence Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Exollence Co., Ltd. operates as a South Korean drug delivery platform technology company. The company is based in Seoul, South Korea. The company was founded in 2019. The CEO is Ki-Hwan Kwon. | Commercial Services |
